Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hiroyasu Kaneda
Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker in Vivo
Clinical Cancer Research
Cancer Research
Oncology
Related publications
BIBF 1120/Nintedanib: A New Triple Angiokinase Inhibitor-Directed Therapy in Patients With Non-Small Cell Lung Cancer
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but Not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model
Neoplasma
Cancer Research
In Vivo Imaging as a Pharmacodynamic Marker
Clinical Cancer Research
Cancer Research
Oncology
Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis
PLoS ONE
Multidisciplinary
In Vivo Monitoring of Fetoplacental Vegfr2 Gene Activity in a Murine Pregnancy Model Using a Vegfr2-Luc Reporter Gene and Bioluminescent Imaging
Reproductive Biology and Endocrinology
Gynecology
Endocrinology
Reproductive Medicine
Developmental Biology
Obstetrics
hTERT Promoter Methylation Status in Peripheral Blood Leukocytes as a Molecular Marker of Head and Neck Cancer Progression
Journal of Applied Genetics
Medicine
Genetics
P3.15-008 [F18]PARPi PET as an in Vivo Pharmacodynamic Biomarker of PARP Inhibitor Therapy in Patient-Derived Xenografts of Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
